APA (7th ed.) Citation

N, D., R, M., & SK, G. (2021). Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients. Critical reviews in oncology/hematology, 162, 103327. https://doi.org/10.1016/j.critrevonc.2021.103327

Chicago Style (17th ed.) Citation

N, Devarajan, Manjunathan R, and Ganesan SK. "Tumor Hypoxia: The Major Culprit Behind Cisplatin Resistance in Cancer Patients." Critical Reviews in Oncology/hematology 162 (2021): 103327. https://doi.org/10.1016/j.critrevonc.2021.103327.

MLA (9th ed.) Citation

N, Devarajan, et al. "Tumor Hypoxia: The Major Culprit Behind Cisplatin Resistance in Cancer Patients." Critical Reviews in Oncology/hematology, vol. 162, 2021, p. 103327, https://doi.org/10.1016/j.critrevonc.2021.103327.